Omada Health (NASDAQ:OMDA) Share Price Breaks Below 200 Day Moving Average Following Insider Selling

Omada Health, Inc. (NASDAQ:OMDA)’s share price crossed below its two hundred day moving average during trading on Friday after an insider sold shares in the company. The stock has a two hundred day moving average of $17.74 and traded as low as $14.75. Omada Health shares last traded at $15.09, with a volume of 4,709,304 shares trading hands.

Specifically, CEO Sean Duffy sold 12,944 shares of the stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $19.22, for a total value of $248,783.68. Following the completion of the sale, the chief executive officer owned 382,594 shares in the company, valued at approximately $7,353,456.68. This trade represents a 3.27% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Wall Street Analyst Weigh In

Several research firms recently commented on OMDA. Barclays cut their price target on Omada Health from $24.00 to $22.00 and set an “overweight” rating on the stock in a research note on Friday. Needham & Company LLC reaffirmed a “buy” rating and issued a $28.00 price objective on shares of Omada Health in a report on Friday, September 11th. JPMorgan Chase & Co. increased their price objective on Omada Health from $26.00 to $30.00 and gave the stock an “overweight” rating in a report on Friday, August 14th. Wells Fargo & Company lowered their target price on Omada Health from $22.00 to $19.00 and set an “equal weight” rating on the stock in a research report on Friday. Finally, Weiss Ratings lowered Omada Health from a “sell (d+)” rating to a “sell (d)” rating in a research report on Thursday, October 8th. Eleven investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $26.33.

Key Omada Health News

Here are the key news stories impacting Omada Health this week:

• Positive Sentiment: Omada reported Q3 revenue of $91 million, up 34% year over year, and total members grew 36% to a record 1.1 million. Net income was $7 million versus a year-ago loss, while adjusted EBITDA increased to $12 million. The company also raised its full-year 2026 financial outlook. Omada Health Reports Third Quarter 2026 Results
• Positive Sentiment: Quarterly revenue exceeded FactSet’s estimate, and reported earnings also topped consensus estimates, providing evidence of stronger-than-expected operating performance. Earnings Flash: Q3 Revenue
• Neutral Sentiment: Unusual options activity was reported after Omada’s earnings, signaling heightened trading interest but not indicating a clear direction for the stock. Unusual Options Volume Report
• Negative Sentiment: Several analysts took a more cautious stance: Wells Fargo cut its price target to $19 and maintained an “equal weight” rating, while Zacks Research downgraded OMDA from “strong buy” to “hold.” Wells Fargo analyst actions Zacks Research analyst action
• Negative Sentiment: Barclays also lowered its target from $24 to $22, although it retained an “overweight” rating. Barclays analyst action

Omada Health Stock Down 20.4%

The stock has a market cap of $923.81 million, a price-to-earnings ratio of 71.86 and a beta of 2.13. The business has a 50-day moving average of $20.14 and a 200-day moving average of $17.74.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings results on Thursday, November 5th. The company reported $0.10 earnings per share for the quarter, beating analysts’ consensus estimates of $0.02 by $0.08. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. The business had revenue of $91.31 million for the quarter. Equities analysts anticipate that Omada Health, Inc. will post 0.09 earnings per share for the current year.

Hedge Funds Weigh In On Omada Health

A number of institutional investors and hedge funds have recently bought and sold shares of OMDA. Sterling Capital Management LLC increased its stake in Omada Health by 1,161.6% during the third quarter. Sterling Capital Management LLC now owns 1,577 shares of the company’s stock valued at $33,000 after acquiring an additional 1,452 shares during the period. Integrated Wealth Concepts LLC acquired a new stake in shares of Omada Health during the second quarter worth approximately $53,000. State of Alaska Department of Revenue acquired a new position in shares of Omada Health in the 3rd quarter worth approximately $59,000. Versant Capital Management Inc increased its holdings in Omada Health by 319.3% during the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after purchasing an additional 2,283 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. acquired a new position in Omada Health during the 3rd quarter worth about $70,000.

About Omada Health

Omada Health, Inc (NASDAQ: OMDA) is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines personalized health coaching, clinical support, behavioral-change tools and connected devices to help members monitor and improve their health.

The company’s offerings focus primarily on cardiometabolic conditions, including diabetes, prediabetes, hypertension and obesity, as well as musculoskeletal conditions. Depending on the program, members may receive access to digital lessons, health tracking, remote monitoring, care teams and clinical guidance through Omada’s technology platform.

Omada Health was founded in 2011 and serves employers, health plans and other healthcare organizations in the United States.